Breaking News Instant updates and real-time market news.

LITE

Lumentum

$41.92

-2.81 (-6.28%)

, OCLR

Bought by LITE

$8.27

-0.165 (-1.96%)

18:16
12/09/18
12/09
18:16
12/09/18
18:16

Huawei CFO seeking bail, Reuters reports

Huawei Chief Financial Officer Meng Wanzhou is fighting to be released on bail after she was arrested on December 1 in Canada at the request of the U.S., according to Reuters. Wanzhou argued that she should be let out on bail while awaiting an extradition hearing due to severe hypertension and fears for her health while incarcerated in Canada, the publication added, citing court documents released on Sunday. According to reports, Huawei accounted for nearly 17% of Lumentum's (LITE) sales in FY17, about 15% of FY17 sales for Oclaro (OCLR) and 11% of FY17 sales for Finisar (FNSR). The company competes in China with ZTE (ZTCOY), Infinera (INFN) and Ciena (CIEN). Reference Link

LITE

Lumentum

$41.92

-2.81 (-6.28%)

OCLR

Bought by LITE

$8.27

-0.165 (-1.96%)

FNSR

Acquired by IIVI

$22.49

-0.53 (-2.30%)

ZTCOY

ZTE Corp.

$0.00

(0.00%)

INFN

Infinera

$4.38

-0.21 (-4.58%)

CIEN

Ciena

$31.30

-0.95 (-2.95%)

  • 13

    Dec

LITE Lumentum
$41.92

-2.81 (-6.28%)

12/06/18
MKMP
12/06/18
DOWNGRADE
MKMP
Neutral
Finisar downgraded to Neutral from Buy at MKM Partners
MKM Partners analyst Michael Genovese downgraded Finisar (FNSR) to Neutral from Buy with a price target of $24 after its merger agreement with II-VI (IIVI) announced last month. The analyst further notes that Q4 is trending well for the optical components group which also includes Lumentum (LITE) and Oclaro (OCLR), but believes that the guidance for March will be "sequentially down due to annual price negotiations and Chinese New Year".
11/14/18
DADA
11/14/18
NO CHANGE
Target $72
DADA
Neutral
Qorvo price target lowered to $72 from $81 at DA Davidson
DA Davidson analyst Thomas Diffely lowered his price target on Qorvo (QRVO) to $72 and kept his Neutral rating after the company cut its Q3 earnings guidance to reflect the expectations of a weaker high-end smartphone demand. The analyst believes that the "softer than expected" launch of the new iPhones by Apple (AAPL) has " triggered a rapid change in order flow over the past couple of weeks" and anticipates similar announcements from other Apple suppliers to track reduced guidance by Qorvo and Lumentum (LITE).
11/26/18
LOOP
11/26/18
NO CHANGE
Target $225
LOOP
Buy
Apple price target lowered to $225 from $259 at Loop Capital
Loop Capital analyst Ananda Baruah lowered his price target on Apple (AAPL) to $225 and also lowered his Q4 iPhone shipment target to 75M from 80M and 2019 target to 204M from 227M. The analyst cites the latest guidance revisions from Lumentum (LITE) along with reports that Apple's iPhone assembler Foxconn is lowering its output expectations. Baruah keeps his Buy rating on Apple, saying that it remains an "attractive long-term investment" given its median multiple of 15-times earnings, but also warns that the company could announce its guidance update as soon as today after meeting with Foxconn, which may prompt him to make additional estimate reductions.
11/28/18
LOOP
11/28/18
NO CHANGE
Target $56
LOOP
Buy
Lumentum price target raised to $56 from $47 at Loop Capital
Loop Capital analyst James Kisner raised his price target on Lumentum (LITE) to $56 and kept his Buy rating, opting for a "long view" on the stock following its November 12th pre-announcement regarding order cuts by Apple (AAPL). The analyst believes that the sell-off in Lumentum stock has given it a "very compelling" valuation and sees his new FY20 EPS view as "conservative and very achievable". Kisner further relates that his conversations with the management indicate that the company "has not yet received an updated forecast from Apple", with some possibility that "this information simply represents 'reverberations' of the same prior cuts, just for different parts of the supply chain."
OCLR Bought by LITE
$8.27

-0.165 (-1.96%)

11/13/18
PIPR
11/13/18
NO CHANGE
Target $72
PIPR
Overweight
Piper remains buyer of Lumentum following yesterday's 33% decline
Piper Jaffray analyst Troy Jensen remains a buyer of Lumentum (LITE) shares following yesterday's 33% decline. The reduced forecast at Apple (AAPL) has nothing to do with lost share for Lumentum, rather it is more indicative of lower sales forecasts at this key account, Jensen tells investors in a research note. The analyst continues to believe the 3D sensing market "will grow handsomely" with Apple and he notes that Android phones are just beginning their adoption. He also sees a pending opportunity for world facing 3D sensing applications. Further, the core telco optics market is in the early innings of an upgrade cycle, which should provide a "nice tailwind" for Lumentum, says Jensen. He also thinks the pending acquisition of Oclaro (OCLR) could also be a catalyst for the shares given the earnings accretion once the merger gets approval. The analyst lowered his price target for Lumentum to $72 from $85 and reiterates an Overweight rating on the name.
11/12/18
CHLM
11/12/18
DOWNGRADE
Target $24
CHLM
Hold
Finisar downgraded to Hold from Buy at Craig-Hallum
Craig-Hallum analyst Richard Shannon downgraded Finisar (FNSR) to Hold from Buy and raised his price target on the shares to $24 from $23. The analyst believes that II-VI's (IIVI) $26/share cash and stock offer for the company, which was a 38% premium to the close on November 8th, is more than a fair deal, given that Lumentum's (LITE) offer premium for Oclaro (OCLR) earlier this year was 27%. Shannon has some doubts about whether this deal will close given the Lumentum/Oclaro deal has not yet closed and the intensifying political standoff between the US and China, but also admits II-VI and Finisar would not have agreed to this deal if there was not a good chance of closing.
09/05/18
NEED
09/05/18
NO CHANGE
Target $90
NEED
Strong Buy
Lumentum price target raised to $90 from $80 at Needham
Needham analyst Alex Henderson raised his price target on Lumentum (LITE) to $90 and kept his Strong Buy rating, saying the company is the "strongest" name in the Optical space even though its valuation is the "lowest". Henderson notes that demand in Optical market is accelerating and 3D "looks set to blossom", even as the stock trades at "just 11.5-times" enterprise value to EBITDA. The analyst further states that Lumentum's competition in 3D is "slow to ramp", adding that he anticipates the approved Oclaro (OCLR) acquisition this year to yield up to $1 in earnings per share.
FNSR Acquired by IIVI
$22.49

-0.53 (-2.30%)

12/06/18
MKMP
12/06/18
DOWNGRADE
MKMP
Neutral
Finisar downgraded to Neutral from Buy at MKM Partners
12/06/18
JEFF
12/06/18
DOWNGRADE
Target $23
JEFF
Hold
Finisar downgraded to Hold from Buy at Jefferies
Jefferies analyst George Notter downgraded Finisar (FNSR) to Hold saying competing takeover bids to II-VI's (IIVI) are unlikely. The analyst views the deal price as "appropriate."
11/13/18
LOOP
11/13/18
NO CHANGE
Target $43
LOOP
Buy
II-VI price target lowered to $43 from $55 at Loop Capital
Loop Capital analyst James Kisner lowered his price target on II-VI (IIVI) to $43, saying it is "prudent" to reduce his estimates for 3D sensing after the negative pre-announcement by Lumentum (LITE). The analyst notes that the company's Laser Solutions business may also slow in FY19, lowering his EPS forecast for next year to $2.29 from $2.53. Separately, Kisner is also positive on II-VI's proposed Finisar (FNSR) merger, stating that even under the conservative projections for the latter, the transaction is "likely very accretive".
ZTCOY ZTE Corp.
$0.00

(0.00%)

08/23/18
PIPR
08/23/18
UPGRADE
Target $26
PIPR
Overweight
Finisar upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded Finisar (FNSR) to Overweight from Neutral and raised his price target for the shares to $26 from $18. The shares closed yesterday down 95c, of 5%, to $18.65. China demand is returning via Huawei and ZTE (ZTCOY), Finisar is facing easy comps following five quarters of depressed demand and the upcoming 400G cycle should provide a tailwind in 2019, Jensen tells investors in a research note. On top of improving optical industry dynamics, the analyst believes Finisar's new CEO will improve the cost structure and execution at the company and drive better profitability. Now is a "great time" to revisit owning the shares, Jensen contends. The analyst this morning also upgraded Acacia Communications (ACIA) to Overweight from Neutral.
08/16/18
RILY
08/16/18
NO CHANGE
Target $50
RILY
Buy
Fabrinet price target raised to $50 from $40 at B. Riley FBR
B. Riley FBR analyst Dave Kang maintained a Buy rating on Fabrinet (FN) and raised his price target for shares to $50 from $40 ahead of the company's Q4 earnings on August 20, which he expects will be above consensus, as the latest industry data indicates that optical demand continues to improve after a 2017 correction. Kang says he remains a buyer into the print, and that Fabrinet should get a boost with the ban on ZTE (ZTCOY) lifted.
08/23/18
PIPR
08/23/18
UPGRADE
Target $46
PIPR
Overweight
Acacia Communications upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Troy Jensen upgraded Acacia Communications (ACIA) to Overweight and raised his price target for the shares to $46 from $38. Demand for optical is improving and Acacia is the best way to play the upcoming 400G cycle, Jensen tells investors in a research note. He believes the company's revenue growth will accelerate amid easy comps, improving demand from ZTE (ZTCOY), recent design wins and upcoming product cycles. Acacia can return to profitability levels seen before the China/ZTE slowdown, the analyst contends.
08/31/18
ROTH
08/31/18
NO CHANGE
Target $7
ROTH
Buy
Roth Capital encouraged by good reviews for Pixelworks-powered Axon 9
Roth Capital analyst Suji Desilva said he was encouraged by positive reviews for ZTE's (ZTCOY) Axon 9 smartphone, which uses Pixelworks' (PXLW) Iris mobile processor. Of note, reviews have emphasized the high aspect ratio OLED display and viewing quality, affirming his constructive thesis on the value of Pixelworks' core video technology, Desilva tells investors. He raised his price target on Pixelworks shares to $7 from $6 and maintains a Buy rating on the stock.
INFN Infinera
$4.38

-0.21 (-4.58%)

11/13/18
MSCO
11/13/18
DOWNGRADE
Target $6
MSCO
Equal Weight
Infinera downgraded to Equal Weight after analyst day delay at Morgan Stanley
As previously reported, Morgan Stanley analyst Meta Marshall downgraded Infinera to Equal Weight from Overweight as she sees "no reason to race in" until there are signs that the revenue base has stabilized. The company's recent earnings report revealed that the Coriant business is in worse condition than expected, noted Marshall, who believes the company's postponement of its analyst day leaves few opportunities for a positive rerating in the next 6 months. Marshall lowered her price target on Infinera shares to $6.00 from $9.50 after lowering her 2021 EPS estimate to 40c-60c from the 75c-$1.00 she'd estimated earlier.
11/09/18
JEFF
11/09/18
UPGRADE
Target $5
JEFF
Hold
Infinera upgraded to Hold from Underperform at Jefferies
Jefferies analyst George Notter upgraded Infinera to Hold while lowering his price target for the shares to $5 from $7.75. The analyst cites valuation for the upgrade following this week's post-earnings selloff.
11/13/18
MSCO
11/13/18
DOWNGRADE
Target $6
MSCO
Equal Weight
Infinera downgraded to Equal Weight from Overweight at Morgan Stanley
Morgan Stanley analyst Meta Marshall downgraded Infinera to Equal Weight and lowered his price target for the shares to $6 from $9.50.
11/13/18
11/13/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Lumentum (LITE) downgraded to Neutral from Overweight at JPMorgan with analyst Samik Chatterjee saying yesterday's negative pronouncement underscored the challenges likely to be faced by Apple (AAPL) supply chain companies in delivering to investor expectations as Apple continues to prioritize its premium pricing strategy on iPhones relative to volumes. 2. Best Buy (BBY) downgraded to Neutral from Buy at BofA/Merrill with analyst Curtis Nagle citing expectations for slowing industry growth, difficult comps in key products and cost inflation. 3. Perrigo (PRGO) downgraded to Hold from Buy at Berenberg with analyst Patrick Trucchio saying although the key reason to own Perrigo shares remains intact, namely the U.S. government's push to shift more products from prescription to nonprescription, "too much uncertainty in generics has placed us on the sidelines." 4. Sabra Health Care (SBRA) downgraded to Neutral from Buy at Mizuho with analyst Richard Anderson saying he wants to a take a "pause" until the earnings reset from the "surprise news" of Senior Care stopping rent payments since May becomes better understood. 5. Infinera (INFN) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Meta Marshall saying she sees "no reason to race in" until there are signs that the revenue base has stabilized. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
CIEN Ciena
$31.30

-0.95 (-2.95%)

12/06/18
JPMS
12/06/18
NO CHANGE
JPMS
JPMorgan adds Cisco to Analyst Focus List, removes Ciena
JPMorgan analyst Samik Chatterjee removed Ciena (CIEN) from his firm's Analyst Focus List following the year-to-date share price performance of 48%. The analyst, however, keeps an Overweight rating on the shares as he still sees 24% upside from current levels. Heading into 2019, he added Overweight-rated Cisco Systems (CSCO) to the Analyst Focus List as a value idea. Cisco is now his top pick within his Networking Equipment/IT Hardware coverage given its "accelerating" product momentum, secular transformation to software and recurring revenue, and potential for "greater upside from re-rating of the shares."
11/20/18
NEED
11/20/18
DOWNGRADE
NEED
Hold
Ciena downgraded to Hold from Buy at Needham
Needham analyst Alex Henderson downgraded Ciena to Hold, saying that after a "nice run" supported by reduced competition, strong growth in India, and key contract wins from NTT, it was time to move to the sidelines. The analyst believes that the stock now reflects "a lot of good news" and warns that the management may guide cautiously for 2019 based on tougher comps and expectations of the competition launching a 400G-600G product. Henderson also sees Ciena's valuation at 18-times enterprise value to expected forward EBITDA multiple as "non inexpensive".
10/22/18
STFL
10/22/18
INITIATION
Target $35
STFL
Buy
Ciena resumed with a Buy at Stifel
Stifel analyst John Marchetti resumed Ciena with a Buy rating and a price target of $35, citing its position as a "leading vendor of optical networking systems servicing long-haul, metro, and datacenter interconnect communications networks". The analyst expects the company to return to "market growth driven by bandwidth demand across multiple target market segments" along with more specific growth drivers like opportunities around India market, DCI share gains, and customer and revenue diversification efforts that should yield "operating margin growth and drive multiple expansion."
10/03/18
RSBL
10/03/18
NO CHANGE
RSBL
Neutral
Rosenblatt raises Ciena target, lowers Infinera's on expected CenturyLink shift
Rosenblatt analyst Ryan Koontz said he now expects Ciena (CIEN) to secure the lead optical supplier contract at CenturyLink (CTL) that he and many others had previously viewed as incumbent Infinera's (INFN) to lose. Koontz, who estimates the value of the contract for Ciena at $150M-$200M per year, modestly increased his 2019 revenue and earnings estimates and raised his price target to $33 from $31, though keeps a Neutral rating on the stock given the shares' recent strength. He cut his 2019 stand-alone Infinera revenue and earnings estimates and lowered his price target on the shares to $9 from $11.50, but maintains a Buy rating given the "precipitous" recent decline in the stock.

TODAY'S FREE FLY STORIES

DXC

DXC Technology

$29.63

-0.45 (-1.50%)

15:04
11/11/19
11/11
15:04
11/11/19
15:04
Options
DXC Technology options imply 23.0% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

MRK

Merck

$83.09

-0.5 (-0.60%)

15:01
11/11/19
11/11
15:01
11/11/19
15:01
Hot Stocks
Merck reports ERVEBO vaccine granted conditional approval in EU »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Nov

  • 07

    Dec

  • 24

    Jan

  • 24

    Jan

  • 05

    Feb

  • 14

    Mar

BTI

British American Tobacco

$37.41

0.38 (1.03%)

, MO

Altria Group

$46.49

0.08 (0.17%)

14:51
11/11/19
11/11
14:51
11/11/19
14:51
Hot Stocks
Trump says will meet with representatives of the vaping industry »

U.S. President Donald…

BTI

British American Tobacco

$37.41

0.38 (1.03%)

MO

Altria Group

$46.49

0.08 (0.17%)

IMBBY

Imperial Brands

$0.00

(0.00%)

PM

Philip Morris

$83.70

0.11 (0.13%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

WMGI

Wright Medical

$29.39

-0.01 (-0.03%)

14:49
11/11/19
11/11
14:49
11/11/19
14:49
Options
Wright Medical options imply 3.5% move in share price post-earnings »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COG

Cabot Oil & Gas

$17.86

-0.515 (-2.80%)

14:45
11/11/19
11/11
14:45
11/11/19
14:45
Options
Cabot Oil & Gas call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOT

Total

$54.72

-0.08 (-0.15%)

, USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

14:27
11/11/19
11/11
14:27
11/11/19
14:27
Periodicals
Total CEO sees weak oil demand growth next year, Bloomberg says »

Total CEO Patrick…

TOT

Total

$54.72

-0.08 (-0.15%)

USO

United States Oil Fund

$11.94

-0.055 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

, ACN

Accenture

$189.95

0.34 (0.18%)

14:25
11/11/19
11/11
14:25
11/11/19
14:25
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

ACN

Accenture

$189.95

0.34 (0.18%)

WPP

WPP

$64.60

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

WPP

WPP

$64.60

-0.01 (-0.02%)

, ACN

Accenture

$190.05

0.44 (0.23%)

14:21
11/11/19
11/11
14:21
11/11/19
14:21
Periodicals
Kimberly-Clark moving some ad duties to Accenture from WPP, WSJ says »

Kimberly-Clark (KMB) has…

WPP

WPP

$64.60

-0.01 (-0.02%)

ACN

Accenture

$190.05

0.44 (0.23%)

KMB

Kimberly-Clark

$131.12

-0.37 (-0.28%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 19

    Nov

  • 19

    Dec

  • 23

    Jan

MS

Morgan Stanley

$49.30

0.15 (0.31%)

14:20
11/11/19
11/11
14:20
11/11/19
14:20
Options
Heavy bullish option flow in Morgan Stanley January term »

Heavy bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Nov

  • 12

    Nov

BABA

Alibaba

$186.42

-0.69 (-0.37%)

, AAPL

Apple

$261.99

1.79 (0.69%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Hot Stocks
Alibaba reports 11.11 gross merchandise volume grew 26% year-over-year to $38.4B »

Alibaba Group (BABA)…

BABA

Alibaba

$186.42

-0.69 (-0.37%)

AAPL

Apple

$261.99

1.79 (0.69%)

EL

Estee Lauder

$186.46

-0.81 (-0.43%)

GPS

Gap

$17.01

0.32 (1.92%)

LRLCY

L'Oreal

$0.00

(0.00%)

LEVI

Levi Strauss

$17.07

-0.06 (-0.35%)

NSRGY

Nestle

$0.00

(0.00%)

NKE

Nike

$89.89

0.09 (0.10%)

VFC

VF Corp.

$86.52

-0.56 (-0.64%)

UA

Under Armour

$15.81

-0.07 (-0.44%)

UAA

Under Armour

$17.53

-0.02 (-0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 21

    Nov

  • 06

    Feb

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

14:17
11/11/19
11/11
14:17
11/11/19
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

14:16
11/11/19
11/11
14:16
11/11/19
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$6.05

-0.42 (-6.49%)

14:13
11/11/19
11/11
14:13
11/11/19
14:13
Periodicals
CA governor raises objections to $11B PG&E insurance deal, WSJ reports »

California Governor Gavin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 07

    Jan

AUPH

Aurinia Pharmaceuticals

$5.05

-0.085 (-1.66%)

14:05
11/11/19
11/11
14:05
11/11/19
14:05
Options
Aurinia Pharmaceuticals call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

LPCN

Lipocine

$0.78

-1.945 (-71.38%)

14:04
11/11/19
11/11
14:04
11/11/19
14:04
Recommendations
Lipocine analyst commentary  »

Lipocine price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FIT

Fitbit

$6.93

-0.13 (-1.84%)

13:55
11/11/19
11/11
13:55
11/11/19
13:55
Options
Fitbit put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$7.61

-0.02 (-0.26%)

13:45
11/11/19
11/11
13:45
11/11/19
13:45
Options
Deutsche Bank call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPCN

Lipocine

$0.82

-1.9039 (-69.87%)

13:37
11/11/19
11/11
13:37
11/11/19
13:37
Downgrade
Lipocine rating change  »

Lipocine downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BABA

Alibaba

$185.80

-1.31 (-0.70%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Recommendations
Alibaba analyst commentary  »

Alibaba Singles Day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

S

Sprint

$5.89

-0.22 (-3.60%)

13:35
11/11/19
11/11
13:35
11/11/19
13:35
Options
Sprint put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

GOOG

Alphabet

$1,299.39

-9.97 (-0.76%)

, GOOGL

Alphabet Class A

$1,298.40

-9.58 (-0.73%)

13:34
11/11/19
11/11
13:34
11/11/19
13:34
Periodicals
Google gathering health data on millions of Americans, WSJ reports »

Alphabet's (GOOG,…

GOOG

Alphabet

$1,299.39

-9.97 (-0.76%)

GOOGL

Alphabet Class A

$1,298.40

-9.58 (-0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMK

Weis Markets

$39.40

-0.06 (-0.15%)

, VLGEA

Village Super Market

$26.80

-0.38 (-1.40%)

13:31
11/11/19
11/11
13:31
11/11/19
13:31
Periodicals
Amazon to open grocery store alternative to Whole Foods, CNET says »

CNET's Ben Fox Rubin…

WMK

Weis Markets

$39.40

-0.06 (-0.15%)

VLGEA

Village Super Market

$26.80

-0.38 (-1.40%)

WMT

Walmart

$118.86

-0.55 (-0.46%)

SVU

Supervalu

$0.00

(0.00%)

KR

Kroger

$26.51

-0.5 (-1.85%)

CASY

Casey's General Stores

$166.95

0.07 (0.04%)

AMZN

Amazon.com

$1,770.99

-14.36 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 13

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 19

    Nov

  • 20

    Nov

CDE

Coeur Mining

$6.25

0.305 (5.13%)

13:25
11/11/19
11/11
13:25
11/11/19
13:25
Options
Coeur Mining call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

, JLL

Jones Lang LaSalle

$161.83

0.23 (0.14%)

13:21
11/11/19
11/11
13:21
11/11/19
13:21
Periodicals
We Company outsourcing cleaning staff to JLL, Business Insider reports »

We Company (WE) is…

WE

We Company

$0.00

(0.00%)

JLL

Jones Lang LaSalle

$161.83

0.23 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MGM

MGM Resorts

$31.41

0.01 (0.03%)

, DSS

Document Security

$0.34

0.0059 (1.76%)

13:18
11/11/19
11/11
13:18
11/11/19
13:18
On The Fly
Fly Insider: MGM, IDEXX Laboratories among week's notable insider trades »

Welcome to "Fly Insider,"…

MGM

MGM Resorts

$31.41

0.01 (0.03%)

DSS

Document Security

$0.34

0.0059 (1.76%)

CNFR

Conifer Holdings

$4.32

0.42 (10.77%)

OFIX

Orthofix

$44.42

-0.46 (-1.03%)

LMNX

Luminex

$19.33

0.96 (5.23%)

UBER

Uber

$26.93

-0.08 (-0.30%)

REPL

Replimune Group

$16.69

-0.11 (-0.65%)

TPX

Tempur Sealy

$86.40

0.82 (0.96%)

IDXX

Idexx Laboratories

$253.71

-0.8 (-0.31%)

BX

Blackstone

$51.89

0.475 (0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 19

    Nov

  • 21

    Nov

  • 04

    Dec

  • 09

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.